HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo
Shuang Jiang, Xiaolong Chen Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, China Background: Diabetic retinopathy (DR), one of the most common complications of late-phase diabetes, is associated with many risk factors, among which continuous low-grade inflamma...
Saved in:
Main Authors: | Jiang S (Author), Chen X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The beauty of symmetry: siRNA phosphorodithioate modifications reduce stereocomplexity, ease analysis, and can improve in vivo potency
by: Sophie Schöllkopf, et al.
Published: (2024) -
Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
by: Olga Osipova, et al.
Published: (2020) -
siRNA-optimized Modifications for Enhanced In Vivo Activity
by: Denise M Kenski, et al.
Published: (2012) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022)